Everest Organics Q3 & YTD 2025 Financial Results Submitted, With Unaudited Financial Results & Limited Review Report

Everest Organics Limited has submitted its unaudited financial results for the quarter and nine months ended December 31, 2025. The company's revenue for Q3 2025 was Rs. 5026.85 Lakhs, with domestic sales of Rs. 3970.75 Lakhs and export sales of Rs. 1056.10 Lakhs. The company operates in the Active Pharmaceutical Ingredients (API) business segment. There are 2,63,157 Equity Share Warrantis outstanding, and 1,60,322 equity shares are still in the Unclaimed Suspense Account as of December 31, 2025. The company is undergoing a review by the Audit Committee and the Board of Directors. The company's financial results were prepared in accordance with Ind AS and other accounting principles generally accepted in India.